NAS:IMTX (Germany)  
Immatics NV logo

Immatics NV

$ 11.28 -0.38 (-3.26%) 11:09 PM EST
P/E:
25.49
P/B:
5.41
Market Cap:
$ 709.81M
Enterprise V:
$ 420.79M
Volume:
176.36K
Avg Vol (2M):
241.99K
Also Trade In:
Volume:
176.36K
Market Cap $:
709.81M
PE Ratio:
25.49
Avg Vol (2-Month):
241.99K
Enterprise Value $:
420.79M
PB Ratio:
5.41
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Immatics NV
NAICS : 541713 SIC : 2833
Paul-Ehrlich-Straße 15, Tubingen, BW, DEU, 72076
Description
Immatics NV is engaged in the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's pipeline consists of two lead product classes, engineered Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics (TCER). Each therapeutic modality has distinct attributes to produce the desired therapeutic effect for patients at different disease stages and with different types of tumors focusing on particularly hard-to-treat solid cancers.
Name Current Vs Industry Vs History
Cash-To-Debt 19.76
Equity-to-Asset 0.34
Debt-to-Equity 0.13
Debt-to-EBITDA 0.46
Interest Coverage 13.34
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.33
Distress
Grey
Safe
Beneish M-Score -1.16
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 109.4
3-Year EBITDA Growth Rate -42.3
3-Year EPS without NRI Growth Rate -43.2

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 33.15
9-Day RSI 47.17
14-Day RSI 54.03
6-1 Month Momentum % -1.6
12-1 Month Momentum % -29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.95
Quick Ratio 2.95
Cash Ratio 2.85
Days Sales Outstanding 2.01

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-11-16 Est.)

IMTX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:IMTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 156.882
EPS (TTM) ($) 0.447
Beta 0
Volatility % 58.94
14-Day RSI 54.03
14-Day ATR ($) 0.647785
20-Day SMA ($) 11.5205
12-1 Month Momentum % -29
52-Week Range ($) 5.75 - 16.3
Shares Outstanding (Mil) 62.93

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Immatics NV Filings

Document Form Filing Date
No Filing Data

Headlines

See More